NJBIZ - Pharma Fight over Heartburn Drug
Tuesday, December 23rd, 2008Wyeth Pharmaceuticals last week filed a patent infringement lawsuit against Teva Pharmaceuticals USA Inc. for launching a generic version of Wyeths acid-reflux drug Protonix. But Teva says it won 180 days of marketing exclusivity from the U.S. Food and Drug Administration for 20-milligram and 40-milligram doses of pantoprazole sodium delayed release-or generic Protonix DR-tablets.
Related Results
Protonix formulaProtonix approvalProtonix pushWye…
